Search - tctmd.com

Displaying 281 - 300 of 532

Sort: Relevancy | Date

Presentation TCT 2015

Latest Concepts in Focal Vulnerable Plaque Stabilization: Scaffold Treatment

Presenter: Gregg W. Stone, Renu Virmani, Patrick W. Serruys

October 12, 2015

Presentation TCT 2015

Will PCSK9 Inhibitors Transform the Natural History of Atherosclerosis?

Presenter: Gregg W. Stone, Renu Virmani, Philippe Gabriel Steg

October 12, 2015

Presentation TCT 2015

The Intersection of Plaque Morphology and Endothelial Shear Stress: New Insights From PROSPECT

Presenter: Gregg W. Stone, Renu Virmani, Peter H. Stone

October 12, 2015

Presentation TCT 2015

Integrative Imaging of Atherosclerotic Structure and Biology

Presenter: Gregg W. Stone, Renu Virmani, Ahmed A. Tawakol

October 12, 2015

Presentation TCT 2015

Whats New in Coronary Vulnerable Plaque Detection: Noninvasive Imaging

Presenter: Gregg W. Stone, Renu Virmani, James K. Min

October 12, 2015

Presentation TCT 2015

Insights From BioImage: Vulnerable Plaque Is a Systemic Disease

Presenter: Gregg W. Stone, Renu Virmani, Roxana Mehran

October 12, 2015

Presentation TCT 2015

A Prospective Randomized Trial of Transradial vs Transfemoral Access in Patients Undergoing Coronary Angiography and Intervention

Presenter: Shigeru Saito, Gregg W. Stone, Ron Waksman, Shigeru Saito

October 12, 2015

Presentation TCT 2015

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Run-Lin Gao, Gregg W. Stone, Ron Waksman, Run-Lin Gao

October 12, 2015

Presentation TCT 2015

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Gregg W. Stone, Ron Waksman, Dean J. Kereiakes

October 12, 2015

Presentation TCT 2015

Periprocedural Antiplatelet Therapy: Agent(s) of Choice, Oral vs IV, and Loading Strategies Focused Commentary

Presenter: Robert A. Harrington, Gregg W. Stone, David J. Cohen, Roxana Mehran

October 12, 2015

Presentation TCT 2015

Periprocedural Antiplatelet Therapy: Agent(s) of Choice, Oral vs IV, and Loading Strategies

Presenter: Robert A. Harrington, Gregg W. Stone, David J. Cohen, Marco Valgimigli

October 12, 2015

Presentation TCT 2015

DAPT Duration After DES: Does 1 Size Fit All? Focused Commentary

Presenter: Robert A. Harrington, Gregg W. Stone, David J. Cohen, John A. Bittl

October 12, 2015

Presentation TCT 2015

DAPT Duration After DES: Does 1 Size Fit All?

Presenter: Robert A. Harrington, Gregg W. Stone, David J. Cohen, John A. Bittl

October 12, 2015

Presentation TCT 2015

A Complex NonLeft Main Bifurcation: Function vs Morphology

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone, Jung-Min Ahn

October 11, 2015

Presentation TCT 2015

A Complex Left Main Bifurcation

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone, Marie-Claude Morice

October 11, 2015

Presentation TCT 2015

We Need More Data: STABLE and PREVENT

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

I Want to Treat Vulnerable Plaques: Not Today but Tomorrow (From PROSPECT to PROSPECT ABSORB)

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

Functionally Insignificant Vulnerable Plaque: Just Defer It!

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone, Nico H.J. Pijls

October 11, 2015

Presentation TCT 2015

How to Define Vulnerable Plaque? What Does It Mean?

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone, Akiko Maehara

October 11, 2015

Presentation TCT 2015

NonLeft Main Bifurcation PCI: Insight From CROSS, PERFECT, and DK CRUSH Trials

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone, Young-Hak Kim

October 11, 2015

Advertisement

Latest Concepts in Focal Vulnerable Plaque Stabilization: Scaffold Treatment

Will PCSK9 Inhibitors Transform the Natural History of Atherosclerosis?

The Intersection of Plaque Morphology and Endothelial Shear Stress: New Insights From PROSPECT

Integrative Imaging of Atherosclerotic Structure and Biology

Whats New in Coronary Vulnerable Plaque Detection: Noninvasive Imaging

Insights From BioImage: Vulnerable Plaque Is a Systemic Disease

A Prospective Randomized Trial of Transradial vs Transfemoral Access in Patients Undergoing Coronary Angiography and Intervention

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Periprocedural Antiplatelet Therapy: Agent(s) of Choice, Oral vs IV, and Loading Strategies Focused Commentary

Periprocedural Antiplatelet Therapy: Agent(s) of Choice, Oral vs IV, and Loading Strategies

DAPT Duration After DES: Does 1 Size Fit All? Focused Commentary

DAPT Duration After DES: Does 1 Size Fit All?

A Complex NonLeft Main Bifurcation: Function vs Morphology

A Complex Left Main Bifurcation

We Need More Data: STABLE and PREVENT

I Want to Treat Vulnerable Plaques: Not Today but Tomorrow (From PROSPECT to PROSPECT ABSORB)

Functionally Insignificant Vulnerable Plaque: Just Defer It!

How to Define Vulnerable Plaque? What Does It Mean?

NonLeft Main Bifurcation PCI: Insight From CROSS, PERFECT, and DK CRUSH Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content